All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
Results
2 results
Polyvalent immunoglobulins – Part 2: Use in Belgium
KCE Reports 336C (2020)
Immunoglobulins, which are produced from human plasma, are invaluable and costly medicines used to treat equally rare and sometimes very serious diseases. There is an ever increasing risk of shortage, both in Belgium and worldwide, which means that strategies must urgently be devised with a view to a better control of their supplies and optimisation of the way they are used.
Read more
[Guidelines update]
Please take note of the publication date of this guideline. From a methodological point of view, a guideline is generally considered obsolete after 5 years. It is therefore possible that some parts of this document are no longer relevant.
KCE Reports 43 (2006)
Read more